Clinical Trial

Left Ventricular Reverse Remodeling Evaluation After Surgical Correction of Aortic Regurgitation

Study acronym: ORMIX
Recruiting
View on ClinicalTrials.gov →
Summary
Investigators assume that surgical correction approach to functional mitral regurgitation during intervention for chronic aortic regurgitation in patients with severe enlargement of the left heart chambers influences reverse remodeling of the left ventricle (LV) in the postoperative period. It is suggested that functional mitral regurgitation (MR) provides supra-physiological left ventricle volume overload and this fact plays positive role in early-stage post-operative left ventricle volume and function recovery. LV volume, systolic and diastolic function will be monitored with echocardiography (EchoCG) along with life quality in patients with different grades of functional mitral regurgitation secondary to severe chronic aortic insufficiency after surgical treatment of aortic regurgitation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-29.
Trial Details
NCT Number NCT06805253
Lead Sponsor Petrovsky National Research Centre of Surgery
Collaborators: Voronezh regional clinical hospital #1
Conditions Aortic Valve Regurgitation, Mitral Valve Regurgitation, Left Ventricle Dilated, Left Atrium Dilated, Systolic Left Ventricular Heart Failure, Diastolic Heart Failure
Enrollment 120 participants
Start Date 2024-05-09
Primary Completion 2029-05 (estimated)
Study Completion 2030-05 (estimated)
Updated on ClinicalTrials.gov 2025-06-11